Magnetar Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-71,927
| Closed | -$1.82M | – | 1085 |
|
|
2025
Q1 | $1.82M | Buy |
+71,927
| New | +$1.88M | 0.02% | 283 |
|
|
2024
Q4 | – | Sell |
-25,096
| Closed | -$726K | – | 748 |
|
|
2024
Q3 | $726K | Sell |
25,096
-5,879
| -19% | -$171K | 0.02% | 306 |
|
|
2024
Q2 | $867K | Hold |
30,975
| – | – | 0.02% | 285 |
|
|
2024
Q1 | $860K | Hold |
30,975
| – | – | 0.02% | 263 |
|
|
2023
Q4 | $892K | Hold |
30,975
| – | – | 0.02% | 266 |
|
|
2023
Q3 | $1.03M | Hold |
30,975
| – | – | 0.03% | 244 |
|
|
2023
Q2 | $1.14M | Hold |
30,975
| – | – | 0.02% | 261 |
|
|
2023
Q1 | $1.26M | Hold |
30,975
| – | – | 0.02% | 354 |
|
|
2022
Q4 | $1.59M | Hold |
30,975
| – | – | 0.03% | 453 |
|
|
2022
Q3 | $1.35M | Hold |
30,975
| – | – | 0.02% | 660 |
|
|
2022
Q2 | $1.62K | Hold |
30,975
| – | – | 0.02% | 790 |
|
|
2022
Q1 | $1.6M | Sell |
30,975
-151,670
| -83% | -$7.87M | 0.02% | 715 |
|
|
2021
Q4 | $10.8M | Buy |
182,645
+151,670
| +490% | +$7.51M | 0.11% | 196 |
|
|
2021
Q3 | $1.33M | Hold |
30,975
| – | – | 0.01% | 669 |
|
|
2021
Q2 | $1.21K | Hold |
30,975
| – | – | 0.01% | 678 |
|
|
2021
Q1 | $1.12M | Sell |
30,975
-57,598
| -65% | -$2.05M | 0.01% | 679 |
|
|
2020
Q4 | $3.26M | Buy |
88,573
+55,925
| +171% | +$2.05M | 0.05% | 286 |
|
|
2020
Q3 | $1.14M | Hold |
32,648
| – | – | 0.02% | 327 |
|
|
2020
Q2 | $1.01M | Sell |
32,648
-1,054,000
| -97% | -$35.8M | 0.03% | 190 |
|
|
2020
Q1 | $33.7M | Buy |
1,086,648
+1,054,000
| +3,228% | +$35.9M | 0.81% | 25 |
|
|
2019
Q4 | $1.21M | Buy |
32,648
+16,359
| +100% | +$583K | 0.03% | 201 |
|
|
2019
Q3 | $555K | Buy |
+16,289
| New | +$592K | 0.01% | 329 |
|
|
2019
Q2 | – | Sell |
-23,381
| Closed | -$928K | – | 527 |
|
|
2019
Q1 | $942K | Buy |
+23,381
| New | +$936K | 0.02% | 170 |
|
|
2018
Q1 | – | Sell |
-25,365
| Closed | -$872K | – | 747 |
|
|
2017
Q4 | $872K | Buy |
+25,365
| New | +$865K | 0.02% | 260 |
|
|
2017
Q3 | – | Sell |
-81,404
| Closed | -$2.59M | – | 871 |
|
|
2017
Q2 | $2.59M | Buy |
+81,404
| New | +$2.57M | 0.04% | 199 |
|
|
2016
Q4 | – | Sell |
-39,629
| Closed | -$1.27M | – | 293 |
|
|
2016
Q3 | $1.27M | Sell |
39,629
-622,803
| -94% | -$20.8M | 0.02% | 235 |
|
|
2016
Q2 | $22.1M | Buy |
+662,432
| New | +$21.1M | 0.37% | 73 |
|
|
2015
Q2 | – | Sell |
-65,901
| Closed | -$2.17M | – | 455 |
|
|
2015
Q1 | $2.17M | Buy |
+65,901
| New | +$2.1M | 0.04% | 157 |
|
|
2014
Q4 | – | Sell |
-52,936
| Closed | -$1.49M | – | 218 |
|
|
2014
Q3 | $1.49M | Buy |
+52,936
| New | +$1.49M | 0.02% | 127 |
|
|
2013
Q3 | – | Sell |
-3,152,092
| Closed | -$83.8M | – | 512 |
|
|
2013
Q2 | $83.8M | Buy |
+3,152,092
| New | +$87.1M | 1.83% | 10 |
|
Other funds holding PFE
Magnetar Financial's PFE Position: Q2 2025 in Review
Magnetar Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 71,927 shares — an estimated $1.82M sold.
Magnetar Financial first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $83.8M in Q2 2013. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Magnetar Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Magnetar Financial sold 71,927 Pfizer shares in Q2 2025, an estimated $1.82M.
- Magnetar Financial first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
- Magnetar Financial's Pfizer position peaked at $83.8M in Q2 2013.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Magnetar Financial's 13F filing for Q2 2025, filed 12 Aug 2025.